Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
26.72
+0.54 (2.06%)
Feb 13, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 10.95 billion as of February 13, 2026. Its market cap has decreased by -13.16% in one year.
Market Cap
10.95B
Enterprise Value
8.86B
Revenue
2.74B
Ranking
n/a
PE Ratio
14.49
Stock Price
26.72
Market Cap Chart
Since April 30, 2015, HKG:6826's market cap has increased from 9.34B to 10.95B, an increase of 17.21%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 10.95B | 7.71% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 17.13B |
| Everest Medicines | 13.91B |
| Nanjing Leads Biolabs | 12.66B |
| Guangzhou Innogen Pharmaceutical Group | 12.62B |
| HBM Holdings | 9.79B |
| Abbisko Cayman | 9.05B |
| Alphamab Oncology | 8.86B |
| Lepu Biopharma | 8.77B |